FDA全球物质注册数据库（FDA Global Substance Registration System）
物质名称TORALIZUMAB
异名/同义词ANTI-CD 154 HUMAN-MOUSE MONOCLONAL ANTIBODY
ANTI-CD154
ANTI-CD40L
ANTI-GP39
E-6040
IDEC-131
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 LIGAND) (HUMAN-MOUSE MONOCLONAL IDEC-131 .GAMMA.1 CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-131 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 LIGAND) (HUMAN-MOUSE MONOCLONAL IDEC-131 .GAMMA.1 CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-131 .KAPPA.-CHAIN, DIMER
TORALIZUMAB
TORALIZUMAB [INN]
TORALIZUMAB [USAN]
CAS登记号252662-47-8
物质唯一标识(Unique Ingredient Identifier)KX44A9HM0B
分子式8232
国际化合物标识(International Chemical Identifier,InChI)MM-32
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 /
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System